MA43507B1 - Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue - Google Patents

Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue

Info

Publication number
MA43507B1
MA43507B1 MA43507A MA43507A MA43507B1 MA 43507 B1 MA43507 B1 MA 43507B1 MA 43507 A MA43507 A MA 43507A MA 43507 A MA43507 A MA 43507A MA 43507 B1 MA43507 B1 MA 43507B1
Authority
MA
Morocco
Prior art keywords
dengue virus
compounds
mono
virus replication
indole derivatives
Prior art date
Application number
MA43507A
Other languages
English (en)
French (fr)
Inventor
Tim Jonckers
Pierre Raboisson
Bart Kesteleyn
Jean-François Bonfanti
Dorothée Bardiot
Arnaud Marchand
Original Assignee
Janssen Pharmaceuticals Inc
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Univ Leuven Kath filed Critical Janssen Pharmaceuticals Inc
Priority claimed from PCT/EP2016/059975 external-priority patent/WO2016180696A1/en
Publication of MA43507B1 publication Critical patent/MA43507B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA43507A 2015-05-08 2016-05-04 Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue MA43507B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15166900 2015-05-08
PCT/EP2016/059975 WO2016180696A1 (en) 2015-05-08 2016-05-04 Mono- or di-substituted indole derivatives as dengue viral replication inhibitors

Publications (1)

Publication Number Publication Date
MA43507B1 true MA43507B1 (fr) 2021-08-31

Family

ID=53059008

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43507A MA43507B1 (fr) 2015-05-08 2016-05-04 Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue

Country Status (3)

Country Link
AR (2) AR104504A1 (es)
MA (1) MA43507B1 (es)
MY (1) MY185672A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114989131B (zh) * 2022-05-30 2023-10-24 云南大学 N’-(2-(苯并[1,3]二氧戊烷-5-基)酰基)芳酰肼类化合物及其合成和用途

Also Published As

Publication number Publication date
AR104504A1 (es) 2017-07-26
AR120158A2 (es) 2022-02-02
MY185672A (en) 2021-05-29

Similar Documents

Publication Publication Date Title
MA40768A (fr) Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue
MA42811A (fr) Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue
MA40769B1 (fr) Indoles mono ou di-substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue
MA40111A1 (fr) Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1
MA53399B1 (fr) Pyrazoles substitués en tant qu`inhibiteurs de la kallicréine plasmatique humaine
PH12018502026A1 (en) Substituted indole compound derivatives as dengue viral replication inhibitors
MA45153B1 (fr) Dérivés de carbonucléosides substitués utiles en tant qu'agents anticancéreux
PH12019502577A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12019502201A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12018502077A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12018502015A1 (en) Substituted indole derivatives as dengue viral replication inhibitors
MA42230B1 (fr) Dérivés bicycliques, leur procédé de préparation, et compositions pharmaceutiques les contenant
PH12019502095A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
PH12018502016A1 (en) Substituted indole derivatives as dengue viral replication inhibitors
PH12019502559A1 (en) Substituted indoline derivatives as dengue viral replication inhibitors
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
MA45782B1 (fr) Modulateurs du récepteur de cxcr7 pipéridine
MA40875A (fr) 2,4-diamino-quinoléine substituée servant de nouveaux agents anticancéreux
MA43913B1 (fr) Modulateurs allostériques positifs du récepteur m1 muscarinique
MA43052B1 (fr) Inhibiteurs de la kallicréine plasmatique humaine
MA42769B1 (fr) Dérivés de fluoroindole en tant que modulateurs allostériques positifs du récepteur muscarinique m1
MA39253A1 (fr) Composés hétéroaryle bicycliques substitués utilisés comme agonistes de rxr
MA43507B1 (fr) Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue
MA49994A1 (fr) Composés macrocycliques pour le traitement de maladie
FR3042191B1 (fr) Derives 1,4,8-triazaphenanthrene pour le traitement de maladies neurodegeneratives